↓ Skip to main content

Chemotherapy and/or radiotherapy in combination with surgery for ovarian carcinosarcoma

Overview of attention for article published in Cochrane database of systematic reviews, February 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
1 X user
f1000
1 research highlight platform

Citations

dimensions_citation
39 Dimensions

Readers on

mendeley
121 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Chemotherapy and/or radiotherapy in combination with surgery for ovarian carcinosarcoma
Published in
Cochrane database of systematic reviews, February 2013
DOI 10.1002/14651858.cd006246.pub2
Pubmed ID
Authors

T S Shylasree, Andrew Bryant, Ram Athavale

Abstract

Ovarian carcinosarcoma, also known as malignant mixed Mullerian tumour, is a rare malignant gynaecological tumour constituting about 1% or less of all ovarian cancers. In over 80% of cases, there is extra-ovarian intra-abdominal spread at diagnosis. The primary treatment has traditionally been surgical cytoreduction followed by radiotherapy and chemotherapy or chemotherapy alone. Regimes have included cisplatin alone; a combination of doxorubicin, ifosfamide, dacarbazine, cyclophosphamide, taxol; and various other combinations. The effectiveness of these various regimens appears to be mixed. Therefore, there is a need to clarify if there is an optimum neoadjuvant or adjuvant therapy after surgical cytoreduction for this rare tumour. Also, it is important to address quality of life (QoL) issues related to treatment, particularly toxicity, as the overall prognosis appears to be poor.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 121 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 121 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 14 12%
Student > Bachelor 11 9%
Student > Doctoral Student 11 9%
Researcher 9 7%
Student > Postgraduate 7 6%
Other 24 20%
Unknown 45 37%
Readers by discipline Count As %
Medicine and Dentistry 44 36%
Nursing and Health Professions 8 7%
Unspecified 5 4%
Pharmacology, Toxicology and Pharmaceutical Science 5 4%
Psychology 4 3%
Other 11 9%
Unknown 44 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 May 2013.
All research outputs
#16,721,208
of 25,371,288 outputs
Outputs from Cochrane database of systematic reviews
#10,351
of 11,484 outputs
Outputs of similar age
#127,553
of 205,210 outputs
Outputs of similar age from Cochrane database of systematic reviews
#173
of 201 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,484 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 39.9. This one is in the 8th percentile – i.e., 8% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 205,210 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 35th percentile – i.e., 35% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 201 others from the same source and published within six weeks on either side of this one. This one is in the 11th percentile – i.e., 11% of its contemporaries scored the same or lower than it.